AEs refer to any adverse, unexpected medical events occurring in patients or subjects during or after a medical intervention (such as a drug, vaccine, surgery, or medical device)
Retatrutide (30mg) from NewBioRx is a high-purity synthetic peptide designed as a triple agonist of the GLP-1, GIP, and glucagon (GCGR) receptors, allowing researchers to investigate coordinated incretin signaling and related pathways involved in glucose regulation, lipid metabolism, energy balance, and endocrine communication between tissues
El mecanismo de accin de tirzepatide es nico porque acta como un agonista dual de los receptores GIP y GLP-1
ChalmersJHaworthCFlumePLongMBurgelPDimakouKet al
These findings hint at a much broader therapeutic future for these medications, potentially offering relief for millions beyond the diabetic population